Clinical trials
Completed Cardiomyopathies trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
255 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 6 |
| 2002 | 4 |
| 2003 | 4 |
| 2004 | 9 |
| 2005 | 8 |
| 2006 | 10 |
| 2007 | 9 |
| 2008 | 9 |
| 2009 | 9 |
| 2010 | 13 |
| 2011 | 9 |
| 2012 | 12 |
| 2013 | 9 |
| 2014 | 24 |
| 2015 | 12 |
| 2016 | 19 |
| 2017 | 9 |
| 2018 | 9 |
| 2019 | 6 |
| 2020 | 18 |
| 2021 | 10 |
| 2022 | 12 |
| 2023 | 8 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 255 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 12 |
| Abbott Medical Devices | 8 |
| Mayo Clinic | 7 |
| Scios, Inc. | 5 |
| Washington University School of Medicine | 5 |
| Alnylam Pharmaceuticals | 4 |
| Duke University | 4 |
| Emory University | 4 |
| Medtronic Cardiac Rhythm and Heart Failure | 4 |
| Pfizer | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathies | 255 |
| Heart Failure | 90 |
| Heart Diseases | 27 |
| Cardiovascular Diseases | 23 |
| Amyloidosis | 13 |
| Ventricular Dysfunction | 12 |
| Arrhythmias, Cardiac | 10 |
| Coronary Artery Disease | 10 |
| Death, Sudden, Cardiac | 9 |
| Heart Defects, Congenital | 9 |
Trials
Showing 1 to 25 of 255. Each trial links to its page on Pharma Observatory.
155 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.